Corcept Shares Rise More Than 55% in 6 Months: Here's Why
Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym (mifepristone), which is...
Unbelievable Stock Gains! Why these 7 Micro, Small, and Mid-Cap Stocks Skyrocketed This Week!
Source: Shutterstock The U.S. stock market has taken a significant hit, marking one of the biggest declines in recent times. All major indices are down, largely due to economic uncertainties, including...
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript
ORGO earnings call for the period ending December 31, 2024.